Flexion Therapeutics, Inc.

FDA Regulatory Profile

Flexion Therapeutics, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-1376-2020, Class III) was initiated on May 19, 2020.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1376-2020Class IIIZilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials,May 19, 2020